Finance

Lists
ATOS:NASDAQ
Atossa Therapeutics Inc
$2.68
+1.52%
(+0.040) 1D
Aug 25, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ATOS...
Open
$2.62
High
$2.69
Low
$2.58
Mkt. cap
26.74M
Avg. vol.
65.44K
Volume
49.68K
52-wk high
$19.35
52-wk low
$1.70
EPS
-$4.34
Beta
1.29
Shares outstanding
9.98M
No. of employees
16
Open
$2.62
High
$2.69
Low
$2.58
Mkt. cap
26.74M
Avg. vol.
65.44K
Volume
49.68K
52-wk high
$19.35
52-wk low
$1.70
EPS
-$4.34
Beta
1.29
Shares outstanding
9.98M
No. of employees
16
About Atossa Therapeutics Inc
CEOSteven C. Quay
Employees16
Founded2009
HeadquartersSeattle, Washington, United States
SectorBiotechnology
Websiteatossatherapeutics.com
Analyst ratings
Based on 2 analysts giving stock ratings to ATOS in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for ATOS in the last 3 months.
Highest
Current $2.68
$12.00 (+347.76%)
Average
$11.00 (+310.45%)
Lowest
$10.00 (+273.13%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jason McCarthy
Maxim Group
Buy
Maintained
$10.00
+273.1%
08/11/2026
Michael King
Rodman & Renshaw
Buy
Initiated
$12.00
+347.8%
07/07/2026
Emily Bodnar
H.C. Wainwright
Buy
Maintained
$25.00
+832.8%
05/08/2026
Edward Woo
Ascendiant
Buy
Maintained
$24.00
+795.5%
04/09/2026
Albert Lowe
Craig-Hallum
Buy
Maintained
$10.00
+273.1%
02/12/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
5.37M
6.16M
4.78M
4.90M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.88M
5.28M
5.09M
3.80M
Operating expense
9.25M
11.44M
9.87M
8.69M
Total operating expenses
9.25M
11.44M
9.87M
8.69M
Operating income
-9.25M
-11.44M
-9.87M
-8.69M
Other non operating income
-11.00K
57.00K
-28.00K
-24.00K
EBT including unusual items
-8.69M
-10.94M
-9.59M
-8.49M
EBT excluding unusual items
-8.69M
-10.94M
-9.59M
-8.49M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-8.69M
-10.94M
-9.59M
-8.49M
Net profit margin
-
-
-
-
Earnings per share
-1.05
-1.34
-1.11
-0.95
Interest and investment income
570.00K
442.00K
309.00K
227.00K
Interest expense
-
-
-
-
Net interest expenses
570.00K
442.00K
309.00K
227.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-9.25M
-11.43M
-9.87M
-8.69M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps